輸入代號或公司名稱後按 Enter
6666

羅麗芬-KY

+0.35 (+0.80%)最後更新 2026-09-16
台灣 · 上市 · 生技醫療業
44.3528成交張數12.90本益比1.15股價淨值比4.55%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20251,113年增 -1.2%
毛利率202565.5%最新一期
營業利益率202511.0%最新一期
每股盈餘20252.42年增 +42.4%
會計項目走勢20182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計33.0%32.2%38.7%41.8%39.6%38.1%37.6%34.5%
營業毛利(毛損)67.0%67.8%61.3%58.2%60.4%61.9%62.4%65.5%
營業毛利(毛損)淨額67.0%67.8%61.3%58.2%60.4%61.9%62.4%65.5%
推銷費用11.6%16.1%25.0%24.1%24.4%23.6%26.6%28.4%
管理費用10.3%10.6%21.1%21.8%24.4%25.8%23.1%20.9%
研究發展費用3.0%4.7%8.2%6.6%6.5%5.1%4.6%5.2%
營業費用合計24.9%31.3%54.3%52.4%55.3%54.5%54.3%54.4%
營業利益(損失)42.1%36.5%7.0%5.8%5.1%7.4%8.1%11.0%
利息收入2.6%1.4%0.7%2.0%1.8%2.0%
其他收入1.0%3.4%3.8%2.3%1.8%1.9%2.3%1.9%
其他利益及損失淨額-0.1%-0.5%0.1%0.8%3.2%0.8%0.0%-0.5%
財務成本淨額0.0%0.2%0.2%0.5%0.3%0.2%0.1%
採用權益法認列之關聯企業及合資損益之份額淨額0.0%-0.0%0.0%-0.1%0.0%-0.1%
營業外收入及支出合計0.8%2.9%6.3%4.3%5.3%4.3%3.9%3.2%
稅前淨利(淨損)43.0%39.4%13.3%10.1%10.4%11.7%12.0%14.2%
所得稅費用(利益)合計11.2%5.0%1.0%2.5%4.3%2.9%4.3%4.5%
繼續營業單位本期淨利(淨損)31.8%34.4%12.3%7.6%6.1%8.8%7.7%9.7%
本期淨利(淨損)31.8%34.4%12.3%7.6%6.1%8.8%7.7%9.7%
國外營運機構財務報表換算之兌換差額-0.2%-3.1%1.9%-1.4%1.3%-2.7%4.8%0.3%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目-0.0%0.0%-0.1%0.1%0.0%
後續可能重分類至損益之項目:-3.1%1.9%-1.4%1.3%-2.8%5.0%0.3%
其他綜合損益(淨額)-0.2%-3.1%1.9%-1.4%1.3%-2.8%5.0%0.3%
本期綜合損益總額31.6%31.3%14.2%6.2%7.5%6.0%12.7%10.0%
母公司業主(淨利∕損)31.8%34.4%12.3%7.7%6.3%9.1%7.2%10.3%
非控制權益(淨利∕損)-0.0%-0.1%-0.2%-0.3%0.6%-0.6%
母公司業主(綜合損益)31.6%31.3%14.2%6.3%7.7%6.4%12.0%10.6%
非控制權益(綜合損益)-0.0%-0.1%-0.2%-0.4%0.7%-0.6%
基本每股盈餘0.8%0.7%0.3%0.2%0.1%0.2%0.2%0.2%
繼續營業單位淨利(淨損)0.0%0.0%0.0%0.0%0.0%0.0%0.0%
稀釋每股盈餘0.8%0.7%0.3%0.2%0.1%0.2%0.2%0.2%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。